Coherus Oncology, Inc. Convertible Notes Payable, Current
Coherus Oncology, Inc. (CHRS) had Convertible Notes Payable, Current of $80.98 million as of 2021-09-30, per its 10-Q filed 2021-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2021-11-08
- 2021-09-30: Convertible Notes Payable, Current $80.98M.
- 2021-06-30: Convertible Notes Payable, Current $80.61M.
- 2021-03-31: Convertible Notes Payable, Current $80.24M.
- 2013-12-31: Convertible Notes Payable, Current $1.11M.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2021-09-30 | $80.98M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $80.61M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $80.24M 10-Q · filed 2021-05-06 |
| 2013-12-31 | $1.11M 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |